Intellipharmaceutics (IPCI) Files $30M Mixed Shelf

Intellipharmaceutics International, Inc. (Nasdaq: IPCI), filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $30 million of Common Shares, Preference Shares, Warrants, Subscription Receipts, or any combination thereof.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Singularity Future Technology closes $5M registered direct offering
• Kairos Pharma announces 1-for-7 reverse stock split
• loanDepot receives NYSE non-compliance notice over stock price